膝动脉栓塞治疗轻至重度膝骨关节炎继发膝痛:一年临床结局
这项前瞻性单中心研究纳入33例(37膝)膝骨关节炎患者,行膝动脉栓塞(GAE)治疗。轻中度组(KL 2-3级,28膝)和重度组(KL 4级,9膝)的VAS与WOMAC评分在12个月时均较基线显著下降(均P<0.001),无重大不良事件。作者结论认为GAE耐受良好且有效,可显著改善轻至重度膝骨关节炎患者的疼痛症状和功能。
要点
- GAE使用150-350 μm聚乙烯醇颗粒栓塞膝动脉3-6支分支,所有患者手术成功且无重大不良事件。
- 轻中度组(KL 2-3级)VAS从基线6.6降至12个月3.0,WOMAC从49.4降至27.4(均P<0.001)。
- 重度组(KL 4级)VAS从基线7.3降至12个月4.4,WOMAC从58.1降至40.6(均P<0.001)。
核心结论
- GAE是一种耐受良好且有效的治疗,可显著改善轻至重度膝骨关节炎患者的疼痛症状和功能。
研究设计与样本
- 前瞻性单中心研究,纳入33例患者共37膝,年龄66.6 ± 8.7岁,膝骨关节炎病程>1年且保守治疗>6个月失败后仍有中重度疼痛;基线评估Kellgren-Lawrence分级和MRI MOAKS评分;GAE使用150-350 μm栓塞聚乙烯醇颗粒;主要终点为12个月时VAS和WOMAC评分变化。
诊断标准与关键数值
- 轻中度组为KL 2-3级(n=28膝),重度组为KL 4级(n=9膝);轻中度组VAS基线6.6 vs 12个月3.0、WOMAC基线49.4 vs 12个月27.4(均P<0.001);重度组VAS基线7.3 vs 12个月4.4、WOMAC基线58.1 vs 12个月40.6(均P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the safety and efficacy of genicular artery embolization (GAE) in patients with mild-to-severe knee osteoarthritis up to 12 months after GAE.
MATERIALS & METHODS: This prospective single-center study included patients who had knee osteoarthritis for >1 year with moderate-to-severe pain after failed conservative treatment for >6 months. Baseline imaging features were evaluated to determine Kellgren-Lawrence (KL) grade and magnetic resonance imaging (MOAKS) scores. GAE was performed using 150-350 μm embolic polyvinyl alcohol particles. The visual analog scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores were used to evaluate knee pain, stiffness, and function at baseline and follow-up. The primary endpoints were changes in VAS and WOMAC scores at 12 months.
RESULTS: Thirty-three patients (n = 37 knees) aged 66.6 ± 8.7 years were enrolled. The patients were categorized into two groups: mild-to-moderate osteoarthritis (n = 28, KL grades 2-3) and severe osteoarthritis (n = 9, KL grade 4). GAE was successfully performed in all patients, with no major adverse events. Three to six branches of the genicular artery were embolized. The mean VAS and WOMAC scores in the mild-to-moderate group significantly decreased (6.6 at baseline vs. 3.0 at 12 months and 49.4 vs. 27.4, respectively, all P < 0.001). The mean VAS and WOMAC scores in the severe group significantly decreased at 12 months (7.3 vs. 4.4 and 58.1 vs. 40.6, respectively, all P < 0.001).
CONCLUSION: GAE is a well-tolerated and effective treatment that significantly improves pain symptoms and function in patients with mild-to-severe knee osteoarthritis.
引用
- Sun C, Chen Y, Gao Z, et al. Genicular artery embolization for the treatment of knee pain secondary to mild to severe knee osteoarthritis: One year clinical outcomes. Eur J Radiol. 2024. PMID: 38537608. doi:10.1016/j.ejrad.2024.111443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。